Shares of Tilray Inc (NASDAQ:TLRY – Get Free Report) shot up 2.6% during mid-day trading on Tuesday . The stock traded as high as $1.85 and last traded at $1.79. 6,234,914 shares changed hands during trading, a decline of 76% from the average session volume of 26,475,734 shares. The stock had previously closed at $1.75.
Analyst Ratings Changes
Several research firms have recently issued reports on TLRY. Alliance Global Partners raised their price objective on Tilray from $2.25 to $2.75 and gave the stock a “neutral” rating in a report on Friday, April 5th. Canaccord Genuity Group decreased their price objective on Tilray from $4.25 to $4.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Finally, CIBC decreased their price objective on Tilray from $2.25 to $2.00 and set a “neutral” rating on the stock in a report on Wednesday, April 10th.
Get Our Latest Research Report on Tilray
Tilray Stock Up 1.1 %
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vontobel Holding Ltd. raised its position in Tilray by 2.7% in the fourth quarter. Vontobel Holding Ltd. now owns 278,199 shares of the company’s stock valued at $640,000 after purchasing an additional 7,362 shares during the period. International Assets Investment Management LLC raised its position in Tilray by 179.0% in the fourth quarter. International Assets Investment Management LLC now owns 14,734 shares of the company’s stock valued at $34,000 after purchasing an additional 9,453 shares during the period. CapWealth Advisors LLC raised its position in Tilray by 12.5% in the first quarter. CapWealth Advisors LLC now owns 90,000 shares of the company’s stock valued at $222,000 after purchasing an additional 10,000 shares during the period. Simplicity Wealth LLC purchased a new position in Tilray in the first quarter valued at about $28,000. Finally, RPO LLC purchased a new position in Tilray in the fourth quarter valued at about $28,000. Institutional investors and hedge funds own 9.35% of the company’s stock.
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Read More
- Five stocks we like better than Tilray
- ESG Stocks, What Investors Should Know
- Sales Breakout Sends This Semiconductor Stock to Record High
- Options Trading – Understanding Strike Price
- Surprise Buying Opportunity on This Dividend Aristocrat
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.